229 Users Online
Vaginal Antifungals Market Segmentation By Drugs ( Fluconazole, Nystatin, Flucytosine, Clotrimazole, Ketoconazole, Terbinafine )
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Key Innovation / Development Trends
4. Key Success Factors
4.1. Promotional Strategies, By Key Manufacturers
4.2. Key Regulations
4.3. Reimbursement Scenario
4.4. Pipeline Analysis
4.5. Value Chain Analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Antifungal Drugs Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Impact of the COVID-19 Pandemic
5.2.2. Increasing Product Launch Activities
5.2.3. Prevalence of Vaginal Fungal Infections in HRT Patients
5.2.4. High Rates of Vulvovaginal Candidiasis
5.2.5. Impact on Quality-of-Life
5.2.6. Increasing Number of People with Predisposing Conditions Such as Diabetes Treated with SGLT2 Inhibitors
5.2.7. Growing Problems of Azole Resistance
5.2.8. Toxicity of Antifungal Drugs
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Drug
6.1.2. By Route of Administration
6.1.3. By Distribution Channel
6.1.4. By Country
6.2. 2021 Market Scenario
7. Global Vaginal Antifungals Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022–2032, By Drug
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Drug, 2017 - 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug, 2022 - 2032
8.3.1. Fluconazole
8.3.2. Nystatin
8.3.3. Flucytosine
8.3.4. Clotrimazole
8.3.5. Ketoconazole
8.3.6. Terbinafine
8.3.7. Others
8.4. Market Attractiveness Analysis By Drug
9. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022–2032, By Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2017 - 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 - 2032
9.3.1. Oral
9.3.2. Topical
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022–2032, By Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2017 - 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022–2032, By Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Drug
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Drug
12.4.3. By Route of Administration
12.4.4. By Distribution Channel
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. U.S. Vaginal Antifungals Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast By Market Taxonomy
12.8.1.2.1. By Drug
12.8.1.2.2. By Route of Administration
12.8.1.2.3. By Distribution Channel
12.8.2. Canada Vaginal Antifungals Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast By Market Taxonomy
12.8.2.2.1. By Drug
12.8.2.2.2. By Route of Administration
12.8.2.2.3. By Distribution Channel
13. Latin America Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.1.4.1. By Country
13.3.1.4.2. By Drug
13.3.1.4.3. By Route of Administration
13.3.1.4.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Drug
13.4.3. By Route of Administration
13.4.4. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Mexico Vaginal Antifungals Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast By Market Taxonomy
13.8.1.2.1. By Drug
13.8.1.2.2. By Route of Administration
13.8.1.2.3. By Distribution Channel
13.8.2. Brazil Vaginal Antifungals Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast By Market Taxonomy
13.8.2.2.1. By Country
13.8.2.2.2. By Drug
13.8.2.2.3. By Route of Administration
13.8.2.2.4. By Distribution Channel
13.8.3. Argentina Vaginal Antifungals Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast By Market Taxonomy
13.8.3.2.1. By Drug
13.8.3.2.2. By Route of Administration
13.8.3.2.3. By Distribution Channel
14. Europe Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Drug
14.3.3. By Route of Administration
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug
14.4.3. By Route of Administration
14.4.4. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Vaginal Antifungals Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast By Market Taxonomy
14.8.1.2.1. By Drug
14.8.1.2.2. By Route of Administration
14.8.1.2.3. By Distribution Channel
14.8.2. Italy Vaginal Antifungals Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast By Market Taxonomy
14.8.2.2.1. By Drug
14.8.2.2.2. By Route of Administration
14.8.2.2.3. By Distribution Channel
14.8.3. France Vaginal Antifungals Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast By Market Taxonomy
14.8.3.2.1. By Drug
14.8.3.2.2. By Route of Administration
14.8.3.2.3. By Distribution Channel
14.8.4. U.K. Vaginal Antifungals Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast By Market Taxonomy
14.8.4.2.1. By Drug
14.8.4.2.2. By Route of Administration
14.8.4.2.3. By Distribution Channel
14.8.5. Spain Vaginal Antifungals Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast By Market Taxonomy
14.8.5.2.1. By Drug
14.8.5.2.2. By Route of Administration
14.8.5.2.3. By Distribution Channel
14.8.6. BENELUX Vaginal Antifungals Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast By Market Taxonomy
14.8.6.2.1. By Drug
14.8.6.2.2. By Route of Administration
14.8.6.2.3. By Distribution Channel
14.8.7. Russia Vaginal Antifungals Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast By Market Taxonomy
14.8.7.2.1. By Drug
14.8.7.2.2. By Route of Administration
14.8.7.2.3. By Distribution Channel
15. East Asia Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Drug
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug
15.4.3. By Route of Administration
15.4.4. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Vaginal Antifungals Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast By Market Taxonomy
15.8.1.2.1. By Drug
15.8.1.2.2. By Route of Administration
15.8.1.2.3. By Distribution Channel
15.8.2. Japan Vaginal Antifungals Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast By Market Taxonomy
15.8.2.2.1. By Drug
15.8.2.2.2. By Route of Administration
15.8.2.2.3. By Distribution Channel
15.8.3. South Korea Vaginal Antifungals Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast By Market Taxonomy
15.8.3.2.1. By Drug
15.8.3.2.2. By Route of Administration
15.8.3.2.3. By Distribution Channel
16. South Asia Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Drug
16.3.3. By Route of Administration
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug
16.4.3. By Route of Administration
16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Vaginal Antifungals Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast By Market Taxonomy
16.8.1.2.1. By Drug
16.8.1.2.2. By Route of Administration
16.8.1.2.3. By Distribution Channel
16.8.2. Indonesia Vaginal Antifungals Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast By Market Taxonomy
16.8.2.2.1. By Drug
16.8.2.2.2. By Route of Administration
16.8.2.2.3. By Distribution Channel
16.8.3. Malaysia Vaginal Antifungals Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast By Market Taxonomy
16.8.3.2.1. By Drug
16.8.3.2.2. By Route of Administration
16.8.3.2.3. By Distribution Channel
16.8.4. Thailand Vaginal Antifungals Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast By Market Taxonomy
16.8.4.2.1. By Drug
16.8.4.2.2. By Route of Administration
16.8.4.2.3. By Distribution Channel
17. Oceania Vaginal Antifungals Market 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Drug
17.3.3. By Route of Administration
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Drug
17.4.3. By Route of Administration
17.4.4. By Distribution Channel
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Australia Vaginal Antifungals Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast By Market Taxonomy
17.7.1.2.1. By Drug
17.7.1.2.2. By Route of Administration
17.7.1.2.3. By Distribution Channel
17.7.2. New Zealand Vaginal Antifungals Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast By Market Taxonomy
17.7.2.2.1. By Drug
17.7.2.2.2. By Route of Administration
17.7.2.2.3. By Distribution Channel
18. Middle East and Africa (MEA) Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Drug
18.3.3. By Route of Administration
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Drug
18.4.3. By Route of Administration
18.4.4. By Distribution Channel
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Vaginal Antifungals Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast By Market Taxonomy
18.8.1.2.1. By Drug
18.8.1.2.2. By Route of Administration
18.8.1.2.3. By Distribution Channel
18.8.2. Türkiye Vaginal Antifungals Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast By Market Taxonomy
18.8.2.2.1. By Drug
18.8.2.2.2. By Route of Administration
18.8.2.2.3. By Distribution Channel
18.8.3. South Africa Vaginal Antifungals Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast By Market Taxonomy
18.8.3.2.1. By Drug
18.8.3.2.2. By Route of Administration
18.8.3.2.3. By Distribution Channel
18.8.4. North Africa Vaginal Antifungals Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast By Market Taxonomy
18.8.4.2.1. By Drug
18.8.4.2.2. By Route of Administration
18.8.4.2.3. By Distribution Channel
19. Market Structure Analysis
19.1. Market Analysis By Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Pfizer Inc.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Strategic Overview
20.3.2. Bausch Health Companies Inc
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Strategic Overview
20.3.3. ANI Pharmaceuticals, Inc.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Strategic Overview
20.3.4. Hikma Pharmaceuticals Plc
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Strategic Overview
20.3.5. Lupin Limited
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Strategic Overview
20.3.6. Mycovia Pharmaceuticals, Inc.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Strategic Overview
20.3.7. Glenmark Pharmaceuticals Limited
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Strategic Overview
20.3.8. Unique Pharmaceuticals
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Strategic Overview
20.3.9. PEPTONIC medical AB
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Key Financials
20.3.9.5. SWOT Analysis
20.3.9.6. Strategic Overview
20.3.10. Aurobindo Pharma Limited
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Key Financials
20.3.10.5. SWOT Analysis
20.3.10.6. Strategic Overview
20.3.11. Dr. Reddy's Laboratories
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Key Financials
20.3.11.5. SWOT Analysis
20.3.11.6. Strategic Overview
20.3.12. SCYNEXIS, Inc.
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Key Financials
20.3.12.5. SWOT Analysis
20.3.12.6. Strategic Overview
20.3.13. Basilea Pharmaceutica Ltd.
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Sales Footprint
20.3.13.4. Key Financials
20.3.13.5. SWOT Analysis
20.3.13.6. Strategic Overview
20.3.14. Astellas Pharma Inc.
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Sales Footprint
20.3.14.4. Key Financials
20.3.14.5. SWOT Analysis
20.3.14.6. Strategic Overview
20.3.15. Grupo Ferrer Internacional, S.A.
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Sales Footprint
20.3.15.4. Key Financials
20.3.15.5. SWOT Analysis
20.3.15.6. Strategic Overview
20.3.16. Pacgen Life Science Corporation
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Sales Footprint
20.3.16.4. Key Financials
20.3.16.5. SWOT Analysis
20.3.16.6. Strategic Overview
20.3.17. NovaDigm Therapeutics, Inc.
20.3.17.1. Overview
20.3.17.2. Product Portfolio
20.3.17.3. Sales Footprint
20.3.17.4. Key Financials
20.3.17.5. SWOT Analysis
20.3.17.6. Strategic Overview
20.3.18. Cidara Therapeutics, Inc.
20.3.18.1. Overview
20.3.18.2. Product Portfolio
20.3.18.3. Sales Footprint
20.3.18.4. Key Financials
20.3.18.5. SWOT Analysis
20.3.18.6. Strategic Overview
20.3.19. Amplyx Pharmaceuticals Inc.
20.3.19.1. Overview
20.3.19.2. Product Portfolio
20.3.19.3. Sales Footprint
20.3.19.4. Key Financials
20.3.19.5. SWOT Analysis
20.3.19.6. Strategic Overview
21. Assumptions and Acronyms Used
22. Research Methodology
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032, by Drug
Table 02: Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration
Table 03: Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
Table 04: Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032, by Region
Table 05: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 06: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
Table 07: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration
Table 08: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
Table 09: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 10: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
Table 11: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration
Table 12: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
Table 13: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 14: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
Table 15: Europe Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration
Table 16: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
Table 17: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 18: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
Table 19: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration
Table 20: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
Table 21: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 22: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
Table 23: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration
Table 24: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
Table 25: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 26: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
Table 27: Oceania Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration
Table 28: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
Table 29: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 30: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
Table 31: Middle East & Africa Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration
Table 32: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Global Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
Figure 02: Global Vaginal Antifungals Market Forecast & Y-o-Y Growth, 2022–2032
Figure 03: Global Vaginal Antifungals Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032
Figure 04: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Drug
Figure 05: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Drug
Figure 06: Global Vaginal Antifungals Market Attractiveness Analysis 2022–2032, by Drug
Figure 07: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Route of Administration
Figure 08: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Route of Administration
Figure 09: Global Vaginal Antifungals Market Attractiveness Analysis 2022–2032, by Route of Administration
Figure 10: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel
Figure 11: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Distribution Channel
Figure 12: Global Vaginal Antifungals Market Attractiveness Analysis 2022–2032, by Distribution Channel
Figure 13: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 14: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Region
Figure 15: Global Vaginal Antifungals Market Attractiveness Analysis 2022–2032, by Region
Figure 16: North America Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
Figure 17: North America Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 18: North America Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 19: North America Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 20: North America Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 21: North America Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 22: North America Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
Figure 23: North America Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
Figure 24: North America Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 25: North America Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
Figure 26: U.S. Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 27: Global Vs. U.S. Growth Comparison
Figure 28: U.S. Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 29: U.S. Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 30: U.S. Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 31: Canada Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 32: Global Vs. Canada. Growth Comparison
Figure 33: Canada Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 34: Canada Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 35: Canada Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 36: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
Figure 37: Latin America Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 38: Latin America Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 39: Latin America Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 40: Latin America Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 41: Latin America Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 42: Latin America Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
Figure 43: Latin America Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
Figure 44: Latin America Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 45: Latin America Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
Figure 46: Mexico Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 47: Global Vs Mexico Growth Comparison
Figure 48: Mexico Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 49: Mexico Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 50: Mexico Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 51: Brazil Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 52: Global Vs. Brazil. Growth Comparison
Figure 53: Brazil Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 54: Brazil Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 55: Brazil Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 56: Argentina Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 57: Global Vs Argentina Growth Comparison
Figure 58: Argentina Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 59: Argentina Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 60: Argentina Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 61: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
Figure 62: Europe Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 63: Europe Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 64: Europe Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 65: Europe Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 66: Europe Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 67: Europe Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
Figure 68: Europe Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
Figure 69: Europe Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 70: Europe Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
Figure 71: UK Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 72: Global Vs. UK Growth Comparison
Figure 73: UK Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 74: UK Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 75: UK Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 76: Germany Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 77: Global Vs. Germany Growth Comparison
Figure 78: Germany Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 79: Germany Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 80: Germany Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 81: Italy Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 82: Global Vs. Italy Growth Comparison
Figure 83: Italy Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 84: Italy Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 85: Italy Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 86: France Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 87: Global Vs France Growth Comparison
Figure 88: France Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 89: France Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 90: France Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 91: Spain Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 92: Global Vs Spain Growth Comparison
Figure 93: Spain Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 94: Spain Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 95: Spain Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 96: Russia Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 97: Global Vs Russia Growth Comparison
Figure 98: Russia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 99: Russia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 100: Russia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 101: BENELUX Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 102: Global Vs BENELUX Growth Comparison
Figure 103: BENELUX Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 104: BENELUX Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 105: BENELUX Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 106: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
Figure 107: East Asia Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 108: East Asia Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 109: East Asia Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 110: East Asia Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 111: East Asia Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 112: East Asia Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
Figure 113: East Asia Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
Figure 114: East Asia Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 115: East Asia Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
Figure 116: China Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 117: Global Vs. China Growth Comparison
Figure 118: China Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 119: China Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 120: China Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 121: Japan Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 122: Global Vs. Japan Growth Comparison
Figure 123: Japan Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 124: Japan Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 125: Japan Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 126: South Korea Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 127: Global Vs South Korea Growth Comparison
Figure 128: South Korea Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 129: South Korea Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 130: South Korea Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 131: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
Figure 132: South Asia Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 133: South Asia Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 134: South Asia Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 135: South Asia Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 136: South Asia Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 137: South Asia Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
Figure 138: South Asia Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
Figure 139: South Asia Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 140: South Asia Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
Figure 141: India Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 142: Global Vs. India Growth Comparison
Figure 143: India Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 144: India Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 145: India Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 146: Indonesia Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 147: Global Vs. Indonesia Growth Comparison
Figure 148: Indonesia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 149: Indonesia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 150: Indonesia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 151: Malaysia Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 152: Global Vs. Malaysia Growth Comparison
Figure 153: Malaysia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 154: Malaysia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 155: Malaysia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 156: Thailand Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 157: Global Vs. Thailand Growth Comparison
Figure 158: Thailand Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 159: Thailand Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 160: Thailand Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 161: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
Figure 162: Oceania Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 163: Oceania Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 164: Oceania Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 165: Oceania Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 166: Oceania Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 167: Oceania Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
Figure 168: Oceania Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
Figure 169: Oceania Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 170: Oceania Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
Figure 171: Australia Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 172: Global Vs. Australia Growth Comparison
Figure 173: Australia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 174: Australia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 175: Australia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 176: New Zealand Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 177: Global Vs New Zealand Growth Comparison
Figure 178: New Zealand Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 179: New Zealand Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 180: New Zealand Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 181: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
Figure 182: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
Figure 183: Middle East & Africa Vaginal Antifungals Market Value Share, by Drug (2022 E)
Figure 184: Middle East & Africa Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
Figure 185: Middle East & Africa Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
Figure 186: Middle East & Africa Vaginal Antifungals Market Value Share, by Country (2022 E)
Figure 187: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
Figure 188: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
Figure 189: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 190: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
Figure 191: GCC Countries Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 192: Global Vs GCC Countries Growth Comparison
Figure 193: GCC Countries Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 194: GCC Countries Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 195: GCC Countries Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 196: Türkiye Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 197: Global Vs. Türkiye Growth Comparison
Figure 198: Türkiye Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 199: Türkiye Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 200: Türkiye Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 201: South Africa Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 202: Global Vs. South Africa Growth Comparison
Figure 203: South Africa Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 204: South Africa Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 205: South Africa Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 206: North Africa Vaginal Antifungals Market Value Proportion Analysis, 2021
Figure 207: Global Vs North Africa Growth Comparison
Figure 208: North Africa Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
Figure 209: North Africa Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
Figure 210: North Africa Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
